These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17545011)

  • 1. Genomic biomarkers and heart transplantation.
    Mehra MR; Uber PA
    Heart Fail Clin; 2007 Jan; 3(1):83-6. PubMed ID: 17545011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
    Horwitz PA; Tsai EJ; Putt ME; Gilmore JM; Lepore JJ; Parmacek MS; Kao AC; Desai SS; Goldberg LR; Brozena SC; Jessup ML; Epstein JA; Cappola TP
    Circulation; 2004 Dec; 110(25):3815-21. PubMed ID: 15583081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-expression profiling for rejection surveillance after cardiac transplantation.
    Pham MX; Teuteberg JJ; Kfoury AG; Starling RC; Deng MC; Cappola TP; Kao A; Anderson AS; Cotts WG; Ewald GA; Baran DA; Bogaev RC; Elashoff B; Baron H; Yee J; Valantine HA;
    N Engl J Med; 2010 May; 362(20):1890-900. PubMed ID: 20413602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial.
    Pham MX; Deng MC; Kfoury AG; Teuteberg JJ; Starling RC; Valantine H
    J Heart Lung Transplant; 2007 Aug; 26(8):808-14. PubMed ID: 17692784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-based bio-signature patterns and cardiac allograft rejection.
    Mehra MR; Uber PA; Benitez RM
    Heart Fail Clin; 2010 Jan; 6(1):87-92. PubMed ID: 19945064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
    Karason K; Jernås M; Hägg DA; Svensson PA
    BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear of rejection--monitoring the heart-transplant recipient.
    Jarcho JA
    N Engl J Med; 2010 May; 362(20):1932-3. PubMed ID: 20413601
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
    Patel JK; Kobashigawa JA
    Curr Opin Cardiol; 2006 Mar; 21(2):127-31. PubMed ID: 16470149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data.
    Rosenthal DN; Chin C; Nishimura K; Perry SB; Robbins RC; Reitz B; Bernstein D; Feinstein JA
    J Heart Lung Transplant; 2004 Mar; 23(3):323-9. PubMed ID: 15019642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
    Dixon V; Macauley C; Burch M; Sebire NJ
    Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
    Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
    Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling for monitoring graft rejection in heart transplant recipients.
    Crespo-Leiro MG; Paniagua-Martín MJ; Hermida-Prieto M; Castro-Beiras A
    Transplant Proc; 2009; 41(6):2240-3. PubMed ID: 19715886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endomyocardial biopsy following heart transplantation: results and complications].
    Furrer M; Schneider K; Gallino A; Schneider J; Vogt P; Turina M
    Helv Chir Acta; 1989 Jan; 55(5):629-32. PubMed ID: 2654093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate markers of rejection.
    Austin BA; Taylor DO
    Curr Opin Organ Transplant; 2010 Oct; 15(5):645-9. PubMed ID: 20651597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine surveillance endomyocardial biopsy.
    Sethi GK; Copeland JG
    Ann Thorac Surg; 1997 Nov; 64(5):1230. PubMed ID: 9386683
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene-expression profiling after cardiac transplantation.
    Otton J; Hayward C; Macdonald P
    N Engl J Med; 2010 Sep; 363(14):1374; author reply 1374. PubMed ID: 20879890
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of endomyocardial biopsy in the diagnosis of lymphoproliferative disorder after heart transplantation.
    Fernández-González AL; Herreros-González JM; Pardo Mindán J
    J Heart Lung Transplant; 1994; 13(6):1146. PubMed ID: 7865524
    [No Abstract]   [Full Text] [Related]  

  • 18. Proliferating cell nuclear antigen expression in endomyocardial biopsies is predictive of progression of rejection and the need for enhanced immunosuppression.
    Salom RN; Maguire JA; Esmore D; Hancock WW
    Transplant Proc; 1993 Oct; 25(5):2894-5. PubMed ID: 8105588
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage?
    Mehra MR; Parameshwar J
    J Heart Lung Transplant; 2010 Jun; 29(6):599-602. PubMed ID: 20497885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early screening for antibody-mediated rejection in heart transplant recipients.
    Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
    J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.